B.Y. Yeap

6.4k total citations
65 papers, 2.0k citations indexed

About

B.Y. Yeap is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, B.Y. Yeap has authored 65 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 28 papers in Oncology and 12 papers in Genetics. Recurrent topics in B.Y. Yeap's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (10 papers) and Radiation Therapy and Dosimetry (7 papers). B.Y. Yeap is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (10 papers) and Radiation Therapy and Dosimetry (7 papers). B.Y. Yeap collaborates with scholars based in United States, Canada and Australia. B.Y. Yeap's co-authors include Margaret A. Shipp, Pasi A. Jänne, George P. Canellos, Bruce E. Johnson, Xiao‐Jun Zhao, Tak Takvorian, K Blake, AS Freedman, Jane C. Weeks and Peter Mauch and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

B.Y. Yeap

62 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B.Y. Yeap United States 20 1.0k 805 595 563 295 65 2.0k
Lucia Nogová Germany 24 642 0.6× 683 0.8× 698 1.2× 314 0.6× 184 0.6× 86 1.5k
Scott Cruickshank United States 21 1.0k 1.0× 1.2k 1.5× 237 0.4× 741 1.3× 582 2.0× 56 2.6k
Robert C. Hermann United States 15 868 0.9× 1.0k 1.2× 449 0.8× 397 0.7× 284 1.0× 38 1.8k
B. Audhuy France 20 316 0.3× 986 1.2× 492 0.8× 437 0.8× 375 1.3× 48 1.9k
Yusri Elsayed United States 22 606 0.6× 1.1k 1.4× 235 0.4× 1.1k 1.9× 172 0.6× 51 2.4k
Miriam Tucker United States 7 401 0.4× 951 1.2× 495 0.8× 524 0.9× 135 0.5× 8 1.9k
KA MacLennan United Kingdom 16 310 0.3× 912 1.1× 1.2k 2.0× 443 0.8× 428 1.5× 29 2.0k
Anna Laurell Sweden 19 427 0.4× 778 1.0× 947 1.6× 529 0.9× 666 2.3× 45 1.9k
Carlo Messina Italy 23 540 0.5× 829 1.0× 311 0.5× 374 0.7× 93 0.3× 102 1.7k
Tara Baetz Canada 20 391 0.4× 904 1.1× 514 0.9× 317 0.6× 261 0.9× 71 1.5k

Countries citing papers authored by B.Y. Yeap

Since Specialization
Citations

This map shows the geographic impact of B.Y. Yeap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B.Y. Yeap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B.Y. Yeap more than expected).

Fields of papers citing papers by B.Y. Yeap

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B.Y. Yeap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B.Y. Yeap. The network helps show where B.Y. Yeap may publish in the future.

Co-authorship network of co-authors of B.Y. Yeap

This figure shows the co-authorship network connecting the top 25 collaborators of B.Y. Yeap. A scholar is included among the top collaborators of B.Y. Yeap based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B.Y. Yeap. B.Y. Yeap is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Waliany, Sarah, B.Y. Yeap, Jennifer Peterson, et al.. (2025). Adverse events associated with sequential immune checkpoint inhibitor and alectinib in patients with ALK-rearranged advanced non-small-cell lung cancer. ESMO Open. 10(10). 105842–105842. 1 indexed citations
2.
Koenig, Julie L., John P. Plastaras, B.Y. Yeap, et al.. (2024). Long-Term Outcomes of Definitive Chemoradiation with Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials. International Journal of Radiation Oncology*Biology*Physics. 120(2). S183–S184.
3.
Yeap, B.Y., Nora Horick, A.L. Zietman, et al.. (2024). Prostate Advanced Radiation Technologies Investigating Quality of Life (PARTIQoL): Phase III Randomized Clinical Trial of Proton Therapy vs. IMRT for Localized Prostate Cancer. International Journal of Radiation Oncology*Biology*Physics. 120(2). S1–S1. 6 indexed citations
4.
Kang, Michael Seungcheol, Clayton B. Hess, B.Y. Yeap, et al.. (2024). Eight-Year Results of a Phase II Prospective Trial of Proton Therapy for Non-Metastatic Pediatric Non-Rhabdomyosarcoma Soft Tissue and Bone Sarcomas. International Journal of Radiation Oncology*Biology*Physics. 120(2). e694–e695. 1 indexed citations
5.
Farago, Anna F., B.Y. Yeap, Rebecca S. Heist, et al.. (2019). OA15.01 Combination Olaparib and Temozolomide in Relapsed Small Cell Lung Cancer: Updated Results from Phase 1/2 Clinical Trial. Journal of Thoracic Oncology. 14(10). S246–S246. 1 indexed citations
6.
Parikh, Aparna R., Jeffrey W. Clark, Jennifer Y. Wo, et al.. (2019). Proof of concept of the abscopal effect in MSS GI cancers: A phase 2 study of ipilimumab and nivolumab with radiation in metastatic pancreatic and colorectal adenocarcinoma. Annals of Oncology. 30. iv128–iv128. 2 indexed citations
7.
Moulds, R. F. W., Peter R. Ebeling, Albert G. Frauman, et al.. (2014). Endocrinology Expert Group. Therapeutic Guidelines: endocrinology. Version 5. eCite Digital Repository (University of Tasmania). 2 indexed citations
8.
Shaw, Alice T., Anna M. Varghese, Benjamin Solomon, et al.. (2012). Pemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancer. Annals of Oncology. 24(1). 59–66. 93 indexed citations
9.
Bardwell, Philip D., Ichiro Shimizu, Fabienne Haspot, et al.. (2011). B-Cell-Dependent Memory T Cells Impede Nonmyeloablative Mixed Chimerism Induction in Presensitized Mice. American Journal of Transplantation. 11(11). 2322–2331. 8 indexed citations
10.
Gordon, Gavin J., Liangliang Dong, B.Y. Yeap, et al.. (2009). Four-Gene Expression Ratio Test for Survival in Patients Undergoing Surgery for Mesothelioma. JNCI Journal of the National Cancer Institute. 101(9). 678–686. 66 indexed citations
11.
Yeap, B.Y., et al.. (2007). Inhibitor of apoptosis proteins are regulated by tumour necrosis factor‐α in malignant pleural mesothelioma. The Journal of Pathology. 211(4). 439–446. 55 indexed citations
12.
Liu, Geoffrey, Wei Zhou, B.Y. Yeap, et al.. (2007). XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis. 28(6). 1254–1258. 48 indexed citations
13.
Liu, Geoffrey, Sarada Gurubhagavatula, Wei Zhou, et al.. (2007). Epidermal growth factor receptor polymorphisms and clinical outcomes in non-small-cell lung cancer patients treated with gefitinib. The Pharmacogenomics Journal. 8(2). 129–138. 85 indexed citations
14.
Yeap, B.Y., et al.. (2007). Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma. The Journal of Pathology. 211(4). 447–454. 59 indexed citations
15.
Engelman, J. A., Toru Mukohara, Kreshnik Zejnullahu, et al.. (2006). Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer. Journal of Clinical Investigation. 116(10). 2695–2706. 374 indexed citations
16.
Pandya, Kishan J., B.Y. Yeap, Louis M. Weiner, et al.. (2001). Megestrol and Tamoxifen in Patients With Advanced Endometrial Cancer. American Journal of Clinical Oncology. 24(1). 43–46. 44 indexed citations
17.
Yeap, B.Y., Thomas P. Davis, Ronald H. Blum, et al.. (1996). Double-blind, randomized study of primary hormonal treatment of stage D2 prostate carcinoma: flutamide versus diethylstilbestrol.. Journal of Clinical Oncology. 14(8). 2250–2257. 104 indexed citations
18.
Down, J. D., et al.. (1990). Late Complications Following Total-body Irradiation and Bone Marrow Rescue in Mice: Predominance of Glomerular Nephropathy and Hemolytic Anemia. International Journal of Radiation Biology. 57(3). 551–565. 32 indexed citations
19.
Freedman, AS, Tak Takvorian, KC Anderson, et al.. (1990). Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse.. Journal of Clinical Oncology. 8(5). 784–791. 147 indexed citations
20.
Shipp, Margaret A., et al.. (1990). The m-BACOD combination chemotherapy regimen in large-cell lymphoma: analysis of the completed trial and comparison with the M-BACOD regimen.. Journal of Clinical Oncology. 8(1). 84–93. 108 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026